WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...

WALTHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

(NASDAQ: MORF) stock has soared to a 52-week high, reaching a price level of $56.92, signaling a robust period for the biopharmaceutical company. This peak comes amidst a wave of investor confidence, ...

Monday, Eli Lilly And Co (NYSE:LLY) agreed to acquire Morphic Holding Inc (NASDAQ:MORF) for $57 per share in cash, an aggregate of approximately $3.2 billion. Morphic is a biopharmaceutical company ...

WALTHAM, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...

SAN FRANCISCO--(BUSINESS WIRE)--Morf is on a mission to empower healthcare providers to focus on patient care and not on tedious administrative tasks or IT. They have announced their $3M seed round ...

NAMB+, the for-profit provider of discounted products and services to members of NAMB—The Association of Mortgage Professionals, has announced its latest partnership with Morf Media Inc., a provider ...

Android/iPhone: MORF is a new app that suggests unorthodox uses for everyday items, and it aims to do it even better by allowing users to add their own ideas to the mix. A Morf is basically a clever ...